Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CERo Therapeutics Holdings, Inc. - Common Stock
(NQ:
CERO
)
0.0951
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CERo Therapeutics Holdings, Inc. - Common Stock
< Previous
1
2
3
4
Next >
What's Going On With Cero Therapeutics Stock Tuesday?
↗
June 17, 2025
CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236.
Via
Benzinga
Get insights into the top gainers and losers of Tuesday's pre-market session.
↗
June 17, 2025
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
Get insights into the top gainers and losers of Monday's pre-market session.
↗
June 09, 2025
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
US Stocks Likely To Open On A Mixed Note After S&P 500 Scales 6,000-Mark: 'Whole Globe Is In A Bull Market'
↗
June 09, 2025
U.S. stock futures were flat on Monday after closing higher on Friday. Futures of major benchmark indices were mixed in premarket.
Via
Benzinga
Topics
Stocks
Discover the top movers in Friday's pre-market session.
↗
June 06, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via
Chartmill
Top movers in Friday's pre-market session
↗
May 30, 2025
The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 30, 2025
Via
Benzinga
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
↗
May 30, 2025
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
April 25, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Top stock movements in today's session.
↗
April 25, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Thursday's session: top gainers and losers
↗
April 24, 2025
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Keep an eye on the top gainers and losers in Thursday's session.
↗
April 24, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results
↗
April 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 24, 2025
Via
Benzinga
Which stocks are gapping on Thursday?
↗
April 24, 2025
The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Dow Jumps Over 200 Points; PepsiCo Cuts Earnings Outlook
↗
April 24, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 24, 2025
Via
Benzinga
Top movers in Thursday's pre-market session
↗
March 27, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
CERo Therapeutics Partners With University Of California Davis For Manufacturing Lead Compound For Treating Cancer: Retail Stays Bullish
↗
March 19, 2025
The compound will be used in the company’s Phase 1 clinical trial for Acute Myeloid Leukemia, with the first patient expected to be dosed in the first half of 2025.
Via
Stocktwits
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 13, 2025
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
↗
March 13, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Friday's after hours session: top gainers and losers
↗
January 24, 2025
After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 18, 2024
Via
Benzinga
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
↗
December 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 15, 2024
Via
Benzinga
Nasdaq Tumbles Over 200 Points; Alibaba Posts Upbeat Sales
↗
November 15, 2024
Via
Benzinga
Why Domino's Pizza Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
↗
November 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 12, 2024
Via
Benzinga
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
↗
November 12, 2024
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.